Drug-coated balloons (DCBs) are an alternative to drug eluting stents for the treatment of the in-stent restenosis.
DCBs deliver, anti-proliferative drugs directly to the blood vessel wall through a lipophilic matrix.
It delivers these drugs, eliminating the need for a permanent metallic prosthesis with a durable polymer.
These balloons can be used in coronary, lesions and in peripheral vascular disease.
Among patients undergoing coronary angioplasty for in-stent restenosis, a paclitaxel coated balloon, was superior to an uncoded balloon with respect to target lesion failure (Yeh RW).